Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VESPER trial for prevention of recurrent urinary tract infection
ISRCTN68263889Phase 4Active, not recruiting
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Apr 2025
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of gentamicin, Ialuril, Cystistat, chondroitin sulfate, nitrofurantoin and 3 more in urinary tract infection (UTI) (3 arms), sponsored by Newcastle Hospitals NHS Foundation Trust. Primary endpoint: Rate of symptomatic, antibiotic-treated urinary tract infection. Started Apr 2025; status: active, not recruiting.
02
Drugs
gentamicinIalurilCystistatchondroitin sulfatenitrofurantoin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on ISRCTN68263889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN68263889.